COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection

被引:143
作者
Chi, Wei-Yu [1 ]
Li, Yen-Der [2 ]
Huang, Hsin-Che [3 ]
Chan, Timothy En Haw [4 ,5 ,6 ]
Chow, Sih-Yao [7 ]
Su, Jun-Han [2 ]
Ferrall, Louise [8 ]
Hung, Chien-Fu [8 ,9 ,10 ]
Wu, T-C [8 ,9 ,10 ,11 ,12 ]
机构
[1] Weill Cornell Med, Physiol Biophys & Syst Biol Grad Program, New York, NY USA
[2] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA
[3] Mem Sloan Kettering Canc Ctr, Triinst PhD Program Chem Biol, 1275 York Ave, New York, NY 10021 USA
[4] Max Planck Inst Immunobiol & Epigenet, Int Max Planck Res Sch Immunobiol Epigenet & Meta, Freiburg, Germany
[5] Univ Freiburg, Med Ctr, Dept Urol, Freiburg, Germany
[6] Univ Freiburg, Fac Biol, Freiburg, Germany
[7] EirGenix Inc, Downstream Proc Sci, Hsinchu, Taiwan
[8] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21218 USA
[9] Johns Hopkins Univ, Dept Oncol, Baltimore, MD 21218 USA
[10] Johns Hopkins Univ, Dept Obstet & Gynecol, Baltimore, MD 21218 USA
[11] Johns Hopkins Univ, Dept Microbiol & Immunol, Baltimore, MD 21218 USA
[12] Johns Hopkins Med Inst, CRB 2 Room 309,1550 Orleans St, Baltimore, MD 21231 USA
关键词
COVID-19; Vaccine; Immunity; Variant; SARS-CoV-2; MESSENGER-RNA; BNT162B2; VACCINE; CHADOX1; NCOV-19; NEUTRALIZING ANTIBODY; OMICRON VARIANT; NON-INFERIORITY; UNITED-STATES; SINGLE-BLIND; IMMUNOGENICITY; SAFETY;
D O I
10.1186/s12929-022-00853-8
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Coronavirus Disease 2019 (COVID-19) has been the most severe public health challenge in this century. Two years after its emergence, the rapid development and deployment of effective COVID-19 vaccines have successfully controlled this pandemic and greatly reduced the risk of severe illness and death associated with COVID-19. However, due to its ability to rapidly evolve, the SARS-CoV-2 virus may never be eradicated, and there are many important new topics to work on if we need to live with this virus for a long time. To this end, we hope to provide essential knowledge for researchers who work on the improvement of future COVID-19 vaccines. In this review, we provided an up-to-date summary for current COVID-19 vaccines, discussed the biological basis and clinical impact of SARS-CoV-2 variants and subvariants, and analyzed the effectiveness of various vaccine booster regimens against different SARS-CoV-2 strains. Additionally, we reviewed potential mechanisms of vaccine-induced severe adverse events, summarized current studies regarding immune correlates of protection, and finally, discussed the development of next-generation vaccines.
引用
收藏
页数:27
相关论文
共 291 条
[1]   Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar [J].
Abu-Raddad, Laith J. ;
Chemaitelly, Hiam ;
Bertollini, Roberto .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (08) :799-800
[2]   Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants [J].
Accorsi, Emma K. ;
Britton, Amadea ;
Fleming-Dutra, Katherine E. ;
Smith, Zachary R. ;
Shang, Nong ;
Derado, Gordana ;
Miller, Joseph ;
Schrag, Stephanie J. ;
Verani, Jennifer R. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (07) :639-651
[3]   Safety and immunogenicity of a third-dose homologous BBIBP-CorV boosting vaccination: interim results from a prospective open-label study [J].
Ai, Jingwen ;
Zhang, Yi ;
Zhang, Haocheng ;
Zhang, Qiran ;
Fu, Zhangfan ;
Lin, Ke ;
Song, Jieyu ;
Zhao, Yuanhan ;
Fan, Mingxiang ;
Wang, Hongyu ;
Zhou, Yang ;
Chen, Xiaohua ;
Qiu, Chao ;
Zhang, Wenhong .
EMERGING MICROBES & INFECTIONS, 2022, 11 (01) :639-647
[4]   Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults A Randomized Clinical Trial [J].
Al Kaabi, Nawal ;
Zhang, Yuntao ;
Xia, Shengli ;
Yang, Yunkai ;
Al Qahtani, Manaf M. ;
Abdulrazzaq, Najiba ;
Al Nusair, Majed ;
Hassany, Mohamed ;
Jawad, Jaleela S. ;
Abdalla, Jehad ;
Hussein, Salah Eldin ;
Al Mazrouei, Shamma K. ;
Al Karam, Maysoon ;
Li, Xinguo ;
Yang, Xuqin ;
Wang, Wei ;
Lai, Bonan ;
Chen, Wei ;
Huang, Shihe ;
Wang, Qian ;
Yang, Tian ;
Liu, Yang ;
Ma, Rui ;
Hussain, Zaidoon M. ;
Khan, Tehmina ;
Saifuddin Fasihuddin, Mohammed ;
You, Wangyang ;
Xie, Zhiqiang ;
Zhao, Yuxiu ;
Jiang, Zhiwei ;
Zhao, Guoqing ;
Zhang, Yanbo ;
Mahmoud, Sally ;
ElTantawy, Islam ;
Xiao, Peng ;
Koshy, Ashish ;
Zaher, Walid Abbas ;
Wang, Hui ;
Duan, Kai ;
Pan, An ;
Yang, Xiaoming .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (01) :35-45
[5]   Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents [J].
Ali, Kashif ;
Berman, Gary ;
Zhou, Honghong ;
Deng, Weiping ;
Faughnan, Veronica ;
Coronado-Voges, Maria ;
Ding, Baoyu ;
Dooley, Jacqueline ;
Girard, Bethany ;
Hillebrand, William ;
Pajon, Rolando ;
Miller, Jacqueline M. ;
Leav, Brett ;
McPhee, Roderick .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (24) :2241-2251
[6]  
Andrews N., 2022, N Engl J Med, V386, p1532 1546, DOI [10.1056/NEJMoa21194511:CAS:528:DC+B38XhtFGrsLbN, DOI 10.1056/NEJMOA21194511:CAS:528:DC+B38XHTFGRSLBN]
[7]   Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines [J].
Andrews, Nick ;
Tessier, Elise ;
Stowe, Julia ;
Gower, Charlotte ;
Kirsebom, Freja ;
Simmons, Ruth ;
Gallagher, Eileen ;
Thelwall, Simon ;
Groves, Natalie ;
Dabrera, Gavin ;
Myers, Richard ;
Campbell, Colin N. J. ;
Amirthalingam, Gayatri ;
Edmunds, Matt ;
Zambon, Maria ;
Brown, Kevin ;
Hopkins, Susan ;
Chand, Meera ;
Ladhani, Shamez N. ;
Ramsay, Mary ;
Bernal, Jamie Lopez .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (04) :340-350
[8]  
Niyomnaitham S, 2022, medRxiv, DOI [10.1101/2021.11.29.21266947, 10.1101/2021.11.29.21266947, DOI 10.1101/2021.11.29.21266947]
[9]  
[Anonymous], Enhancing response to Omicron SARS-CoV02 variant: Technical brief and priority actions for Member States
[10]  
[Anonymous], COVID 19 MAP COVID 1